Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2021-11-15 00:00:00 ET · period of report 2021-11-10 · accession 0001209191-21-064449 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-15 | 2021-11-10 | MIRM | Longpre Lara | Chief Development Off | A - Grant | $13.52 | +753 | 85.0K | +0.9% | +$10.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-10 | A | A | 753 | $13.52 | 84,998 | D | — | — |